CTCBIO Inc. (KOSDAQ:060590)
3,005.00
-35.00 (-1.15%)
At close: Sep 23, 2026
CTCBIO Market Cap
CTCBIO has a market cap or net worth of 71.85 billion as of September 25, 2026. Its market cap has decreased by -57.79% in one year.
Market Cap
71.85B
Enterprise Value
93.96B
Revenue
131.54B
Ranking
n/a
PE Ratio
9.51
Stock Price
3,005.00
ChartMarket Cap Chart
Since March 3, 2003, CTCBIO's market cap has increased from 10.66B to 71.85B, an increase of 574.20%. That is a compound annual growth rate of 8.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 71.85B | -35.03% |
| Dec 30, 2025 | 110.58B | -29.39% |
| Dec 30, 2024 | 156.60B | -38.79% |
| Dec 28, 2023 | 255.82B | 69.84% |
| Dec 29, 2022 | 150.63B | -28.80% |
| Dec 30, 2021 | 211.56B | 32.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Choong Ang Vaccine Laboratory | 84.70B |
| EyeGene | 84.30B |
| BIO-FD&C | 79.74B |
| Naturalendo Tech | 74.67B |
| IMGT Co.,Ltd. | 69.86B |
| SunBio,Inc. | 68.77B |
| NovMetaPharma | 67.93B |
| PanGen Biotech | 64.94B |